GGrantIndex
← Leaderboards

Roger Ptak

Southern Research Institute

Google Scholar ↗PubMed ↗ORCID ↗
$24,583,615
Attributed
$24,583,615
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $5.5M · FY2009–21
$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$24,583,615 · 6

By mechanism

N01$24,583,615 · 6

Top collaborators

No co-investigators on record.

Most similar at Southern Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Contracts”

Research focus

ContractsNational Institute Of Allergy And Infectious DiseaseCellsNovel TherapeuticsPrivate SectorServicesPublic Health PrioritiesBaseSourceLocal MicrobicidesAcademiaProduct DevelopmentInvestigational New Drug ApplicationPhase I TrialResearch PersonnelProspectiveHigh Throughput ScreeningFundingBiochemicalPublic HealthPre-ClinicalResourcesHiv-1Hiv Infections

Grant awards (44)

Conduct Hit-to-Lead Progression Studies on Interventional Agents: Identification of Anti-HIV Lead Compounds$404,140
N01 · FY2021 · AI · contact PI
Conduct Confirmatory and Specialized In Vitro Testing and Screening of Interventional Agents in Standard Formats$289,458
N01 · FY2021 · AI · contact PI
Task B05: Comprehensive Viral Screening Panel$336,000
N01 · FY2020 · AI · contact PI
QUANTITATIVE VIRAL OUTGROWTH ASSAY (QVOA) SERVICE RESOURCE$1,764,423
N01 · FY2019 · AI · contact PI
TASK B01: COMPREHENSIVE VIRAL SCREENING PANEL$268,880
N01 · FY2019 · AI · contact PI
In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides: Administration and Data Coordination$138,599
N01 · FY2019 · AI · contact PI
In Vitro Assessment for Antimicrobial Activity Support (Task Area B)$2,500
N01 · FY2019 · AI · contact PI
Hit-to-Lead Progression Studies on Interventional Agents: Identification of Lead Compounds to Inhibit HIV-1$1,999,962
N01 · FY2018 · AI · contact PI
QUANTITATIVE VIRAL OUTGROWTH ASSAY (QVOA) SERVICE RESOURCE$1,720,951
N01 · FY2018 · AI · contact PI
Conduct Hit-to-Lead Progression Studies on Interventional Agents: Identification of Anti-HIV Lead Compounds$499,816
N01 · FY2018 · AI · contact PI
In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides: New Assay Development$295,565
N01 · FY2018 · AI · contact PI
In Vitro Confirmatory Testing and Screening of Interventional Agents in Standard Formats: Identification of Anti-HIV Therapeutics and Topical Microbicides$174,999
N01 · FY2018 · AI · contact PI
In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides: Administration and Data Coordination$134,570
N01 · FY2018 · AI · contact PI
QUANTITATIVE VIRAL OUTGROWTH ASSAY (QVOA) SERVICE RESOURCE$1,678,589
N01 · FY2017 · AI · contact PI
IDENTIFICATION OF ANTI-HIV THERAPEUTICS AND TOPICAL MICROBICIDES$684,610
N01 · FY2017 · AI · contact PI
HIGH THROUGHPUT SCREENING TO IDENTIFY HIV INHIBITORS$386,510
N01 · FY2017 · AI · contact PI
IDENTIFICATION OF ANTI-HIV LEAD COMPOUNDS$319,626
N01 · FY2017 · AI · contact PI
ANNUAL UPDATE OF THE NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION (NCBI) DATABASE$271,236
N01 · FY2017 · AI · contact PI
NEW ASSAY DEVELOPMENT$146,836
N01 · FY2017 · AI · contact PI
Administration and Data Coordination$130,657
N01 · FY2017 · AI · contact PI
QUANTITATIVE VIRAL OUTGROWTH ASSAY (QVOA) SERVICE RESOURCE$1,637,307
N01 · FY2016 · AI · contact PI
IGF::OT::IGF HTS TO IDENTIFY INHIBITORS OF HIV-1 CAPSID DIMERIZATION$999,976
N01 · FY2016 · AI · contact PI
IGF::OT::IGF HTS TO IDENTIFY INHIBITORS OR HIV-1 VPU$776,587
N01 · FY2016 · AI · contact PI
IGF::OT::IGF IDENTIFICATION OF LEAD COMPOUNDS TO INHIBIT HIV-1 REGULATORY PROTEINS$516,565
N01 · FY2016 · AI · contact PI
IGF::OT::IGF IDENTIFICATION OF ANTI-HIV THERAPEUTICS AND TOPICAL MICROBICIDES$516,519
N01 · FY2016 · AI · contact PI
IGF::OT::IGF IDENTIFICATION OF ANTI-HIV LEAD COMPOUNDS$258,213
N01 · FY2016 · AI · contact PI
IGF::OT::IGF ANNUAL UPDATE OF THE NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION (NCBI) DATABASE$257,736
N01 · FY2016 · AI · contact PI
IGF::OT::IGF HIGH THROUGHPUT SCREENING TO IDENTIFY HIV INHIBITORS$254,080
N01 · FY2016 · AI · contact PI
IGF::OT::IGF NEW ASSAY DEVELOPMENT$128,325
N01 · FY2016 · AI · contact PI
Administration and Data Coordination$126,861
N01 · FY2016 · AI · contact PI
IGF::OT::IGF 500,000 COMPOUND SCREEN TO IDENTIFY GAG PROCESSING INHIBITORS$749,989
N01 · FY2015 · AI · contact PI
IGF::OT::IGF IDENTIFICATION OF LEAD COMPOUNDS TO INHIBIT HIV$499,986
N01 · FY2015 · AI · contact PI
IGF::OT::IGF IDENTIFICATION OF ANTI-HIV THERAPEUTICS AND TOPICAL MICROBICIDES$499,969
N01 · FY2015 · AI · contact PI
IGF::OT::IGF IDENTIFICATION OF ANTI-HIV LEAD COMPOUNDS$249,997
N01 · FY2015 · AI · contact PI
IGF::OT::IGF HIGH THROUGHPUT SCREENING TO IDENTIFY HIV INHIBITORS$249,990
N01 · FY2015 · AI · contact PI
IGF::OT::IGF ANNUAL UPDATE OF THE NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION (NCBI) DATABASE$249,990
N01 · FY2015 · AI · contact PI
IGF::OT::IGF NEW ASSAY DEVELOPMENT$124,996
N01 · FY2015 · AI · contact PI
Administration and Data Coordination$123,181
N01 · FY2015 · AI · contact PI
Resources For AIDS Ther.& Dev. : Conf. In Vitro Evaluations HIV Ther.$431,029
N01 · FY2013 · AI · contact PI
Resources For AIDS Ther.& Dev. : Conf. In Vitro Evaluations HIV Ther.$415,425
N01 · FY2012 · AI · contact PI
Resources For AIDS Ther.& Dev. : Conf. In Vitro Evaluations HIV Ther.$400,391
N01 · FY2011 · AI · contact PI
Resources For AIDS Ther.Dev. - Part A: Conf. Vitro Evaluations$385,926
N01 · FY2010 · AI · contact PI
Award of Part B - In Vitro Testing Resources for AIDS Therapeutics Development$2,710,652
N01 · FY2009 · AI · contact PI
Resources For AIDS Ther.Dev. - Part A: Conf. Vitro Evaluations$371,998
N01 · FY2009 · AI · contact PI